Ledger.Open graph →
SEC Form D · Amendment · filed March 2, 2021

Angarus Therapeutics, Inc

Offering
$7.8M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PORTOLA VALLEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Nigel Ray · Portola Valley, CAExec · DirectorChih-Ping Liu · Portola Valley, CADirectorJean Liu · Portola Valley, CADirectorPeter Langecker · Portola Valley, CADirectorStephen Murphy · New York, NYDirectorJohn R. Ruhl · Riverhead, NYDirectorMitch Williams · New York, NYExec · DirectorErkko R. Etula · Riverhead, NYDirectorFai H. Chan · Greenwood Village, CODirectorRobert Mah · RENO, NVExec · DirectorEric Wauthy · Los Angeles, CADirectorDavid Beatty · Burlington, VTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗